Angelman syndrome is rare (~1 in 15,000) but one of the most *actionable* neurogenetic conditions. Thanks to collaboration between FAST, Yale University & EBiSC, a curated iPSC panel now reflects the full range of AS genotypes.

🔗 ebisc.org/search?q=Yui

#AngelmanSyndrome #iPSC #RareDiseases

📢 Today’s the day! Thrilled to kick off the #UKSCN 2025 meeting in Manchester today.

Looking forward to a packed day of talks and discussions.

If you see our team around, come say hi! 👋

🎉 We're excited for the UK Stem Cell Network Inaugural meeting next week!
Looking forward to great talks, new ideas, and connecting with UK researchers.

Who else is here? Let’s meet up!

#UKSCN #iPSCs #Research #StemCells

🧬 New paper in Stem Cell Reports used EBiSC iPSC lines BIONi037-A (ApoE3/E3) and BIONi037-A-4 (ApoE4/E4) to study how APOE genotype impacts cell biology.

Both lines are available via EBiSC👉

(www.cell.com/stem-cell-re...

#iPSC #EBiSC #APOE #Alzheimers

📢 Hello Bluesky!

This is our official account for EBiSC — the European Bank for induced Pluripotent Stem Cells.

We’ll be sharing news on new iPSC lines, publications, data and how we work to enable iPSC science.

Join in the discussion and tell us how we can support you and your research!